Gene Therapy for CNS Disorders Market

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Ex Vivo
        1.2.3 In Vivo
    1.3 Market by Application
        1.3.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy for CNS Disorders Market Perspective (2017-2028)
    2.2 Gene Therapy for CNS Disorders Growth Trends by Region
        2.2.1 Gene Therapy for CNS Disorders Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Therapy for CNS Disorders Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy for CNS Disorders Forecasted Market Size by Region (2023-2028)
    2.3 Gene Therapy for CNS Disorders Market Dynamics
        2.3.1 Gene Therapy for CNS Disorders Industry Trends
        2.3.2 Gene Therapy for CNS Disorders Market Drivers
        2.3.3 Gene Therapy for CNS Disorders Market Challenges
        2.3.4 Gene Therapy for CNS Disorders Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy for CNS Disorders Players by Revenue
        3.1.1 Global Top Gene Therapy for CNS Disorders Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy for CNS Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy for CNS Disorders Revenue
    3.4 Global Gene Therapy for CNS Disorders Market Concentration Ratio
        3.4.1 Global Gene Therapy for CNS Disorders Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for CNS Disorders Revenue in 2021
    3.5 Gene Therapy for CNS Disorders Key Players Head office and Area Served
    3.6 Key Players Gene Therapy for CNS Disorders Product Solution and Service
    3.7 Date of Enter into Gene Therapy for CNS Disorders Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for CNS Disorders Breakdown Data by Type
    4.1 Global Gene Therapy for CNS Disorders Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy for CNS Disorders Forecasted Market Size by Type (2023-2028)
5 Gene Therapy for CNS Disorders Breakdown Data by Application
    5.1 Global Gene Therapy for CNS Disorders Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy for CNS Disorders Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Therapy for CNS Disorders Market Size (2017-2028)
    6.2 North America Gene Therapy for CNS Disorders Market Size by Type
        6.2.1 North America Gene Therapy for CNS Disorders Market Size by Type (2017-2022)
        6.2.2 North America Gene Therapy for CNS Disorders Market Size by Type (2023-2028)
        6.2.3 North America Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    6.3 North America Gene Therapy for CNS Disorders Market Size by Application
        6.3.1 North America Gene Therapy for CNS Disorders Market Size by Application (2017-2022)
        6.3.2 North America Gene Therapy for CNS Disorders Market Size by Application (2023-2028)
        6.3.3 North America Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    6.4 North America Gene Therapy for CNS Disorders Market Size by Country
        6.4.1 North America Gene Therapy for CNS Disorders Market Size by Country (2017-2022)
        6.4.2 North America Gene Therapy for CNS Disorders Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gene Therapy for CNS Disorders Market Size (2017-2028)
    7.2 Europe Gene Therapy for CNS Disorders Market Size by Type
        7.2.1 Europe Gene Therapy for CNS Disorders Market Size by Type (2017-2022)
        7.2.2 Europe Gene Therapy for CNS Disorders Market Size by Type (2023-2028)
        7.2.3 Europe Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    7.3 Europe Gene Therapy for CNS Disorders Market Size by Application
        7.3.1 Europe Gene Therapy for CNS Disorders Market Size by Application (2017-2022)
        7.3.2 Europe Gene Therapy for CNS Disorders Market Size by Application (2023-2028)
        7.3.3 Europe Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    7.4 Europe Gene Therapy for CNS Disorders Market Size by Country
        7.4.1 Europe Gene Therapy for CNS Disorders Market Size by Country (2017-2022)
        7.4.2 Europe Gene Therapy for CNS Disorders Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size (2017-2028)
    8.2 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Type
        8.2.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Application
        8.3.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region
        8.4.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gene Therapy for CNS Disorders Market Size (2017-2028)
    9.2 Latin America Gene Therapy for CNS Disorders Market Size by Type
        9.2.1 Latin America Gene Therapy for CNS Disorders Market Size by Type (2017-2022)
        9.2.2 Latin America Gene Therapy for CNS Disorders Market Size by Type (2023-2028)
        9.2.3 Latin America Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    9.3 Latin America Gene Therapy for CNS Disorders Market Size by Application
        9.3.1 Latin America Gene Therapy for CNS Disorders Market Size by Application (2017-2022)
        9.3.2 Latin America Gene Therapy for CNS Disorders Market Size by Application (2023-2028)
        9.3.3 Latin America Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    9.4 Latin America Gene Therapy for CNS Disorders Market Size by Country
        9.4.1 Latin America Gene Therapy for CNS Disorders Market Size by Country (2017-2022)
        9.4.2 Latin America Gene Therapy for CNS Disorders Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy for CNS Disorders Market Size (2017-2028)
    10.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type
        10.2.1 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gene Therapy for CNS Disorders Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application
        10.3.1 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gene Therapy for CNS Disorders Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country
        10.4.1 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Gilead (Kite Pharma)
        11.1.1 Gilead (Kite Pharma) Company Details
        11.1.2 Gilead (Kite Pharma) Business Overview
        11.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Introduction
        11.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        11.1.5 Gilead (Kite Pharma) Recent Developments
    11.2 Amgen (BioVex)
        11.2.1 Amgen (BioVex) Company Details
        11.2.2 Amgen (BioVex) Business Overview
        11.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Introduction
        11.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        11.2.5 Amgen (BioVex) Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Gene Therapy for CNS Disorders Introduction
        11.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Roche (Spark Therapeutics)
        11.4.1 Roche (Spark Therapeutics) Company Details
        11.4.2 Roche (Spark Therapeutics) Business Overview
        11.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Introduction
        11.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        11.4.5 Roche (Spark Therapeutics) Recent Developments
    11.5 Bluebird Bio
        11.5.1 Bluebird Bio Company Details
        11.5.2 Bluebird Bio Business Overview
        11.5.3 Bluebird Bio Gene Therapy for CNS Disorders Introduction
        11.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2017-2022)
        11.5.5 Bluebird Bio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Ex Vivo
    Table 3. Key Players of In Vivo
    Table 4. Global Gene Therapy for CNS Disorders Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Gene Therapy for CNS Disorders Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gene Therapy for CNS Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Gene Therapy for CNS Disorders Market Share by Region (2017-2022)
    Table 8. Global Gene Therapy for CNS Disorders Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Gene Therapy for CNS Disorders Market Share by Region (2023-2028)
    Table 10. Gene Therapy for CNS Disorders Market Trends
    Table 11. Gene Therapy for CNS Disorders Market Drivers
    Table 12. Gene Therapy for CNS Disorders Market Challenges
    Table 13. Gene Therapy for CNS Disorders Market Restraints
    Table 14. Global Gene Therapy for CNS Disorders Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Gene Therapy for CNS Disorders Revenue Share by Players (2017-2022)
    Table 16. Global Top Gene Therapy for CNS Disorders by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for CNS Disorders as of 2021)
    Table 17. Ranking of Global Top Gene Therapy for CNS Disorders Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Gene Therapy for CNS Disorders Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapy for CNS Disorders Product Solution and Service
    Table 21. Date of Enter into Gene Therapy for CNS Disorders Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapy for CNS Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2017-2022)
    Table 25. Global Gene Therapy for CNS Disorders Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2023-2028)
    Table 27. Global Gene Therapy for CNS Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Gene Therapy for CNS Disorders Revenue Share by Application (2017-2022)
    Table 29. Global Gene Therapy for CNS Disorders Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Gene Therapy for CNS Disorders Revenue Share by Application (2023-2028)
    Table 31. North America Gene Therapy for CNS Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Gene Therapy for CNS Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Gene Therapy for CNS Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Gene Therapy for CNS Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Gene Therapy for CNS Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Gene Therapy for CNS Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Gene Therapy for CNS Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Gene Therapy for CNS Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Gene Therapy for CNS Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Gene Therapy for CNS Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Gene Therapy for CNS Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Gene Therapy for CNS Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Gene Therapy for CNS Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Gene Therapy for CNS Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Gene Therapy for CNS Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Gene Therapy for CNS Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Gene Therapy for CNS Disorders Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Gene Therapy for CNS Disorders Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Gene Therapy for CNS Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Gene Therapy for CNS Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Gene Therapy for CNS Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Gene Therapy for CNS Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Gene Therapy for CNS Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Gene Therapy for CNS Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Gene Therapy for CNS Disorders Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Gene Therapy for CNS Disorders Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Gene Therapy for CNS Disorders Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Gene Therapy for CNS Disorders Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Gene Therapy for CNS Disorders Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Gene Therapy for CNS Disorders Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Gilead (Kite Pharma) Company Details
    Table 62. Gilead (Kite Pharma) Business Overview
    Table 63. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product
    Table 64. Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 65. Gilead (Kite Pharma) Recent Developments
    Table 66. Amgen (BioVex) Company Details
    Table 67. Amgen (BioVex) Business Overview
    Table 68. Amgen (BioVex) Gene Therapy for CNS Disorders Product
    Table 69. Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 70. Amgen (BioVex) Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Gene Therapy for CNS Disorders Product
    Table 74. Novartis Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Roche (Spark Therapeutics) Company Details
    Table 77. Roche (Spark Therapeutics) Business Overview
    Table 78. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product
    Table 79. Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 80. Roche (Spark Therapeutics) Recent Developments
    Table 81. Bluebird Bio Company Details
    Table 82. Bluebird Bio Business Overview
    Table 83. Bluebird Bio Gene Therapy for CNS Disorders Product
    Table 84. Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2017-2022) & (US$ Million)
    Table 85. Bluebird Bio Recent Developments
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy for CNS Disorders Market Share by Type: 2021 VS 2028
    Figure 2. Ex Vivo Features
    Figure 3. In Vivo Features
    Figure 4. Global Gene Therapy for CNS Disorders Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Gene Therapy for CNS Disorders Report Years Considered
    Figure 9. Global Gene Therapy for CNS Disorders Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Gene Therapy for CNS Disorders Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Gene Therapy for CNS Disorders Market Share by Region: 2021 VS 2028
    Figure 12. Global Gene Therapy for CNS Disorders Market Share by Players in 2021
    Figure 13. Global Top Gene Therapy for CNS Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for CNS Disorders as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Gene Therapy for CNS Disorders Revenue in 2021
    Figure 15. North America Gene Therapy for CNS Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Gene Therapy for CNS Disorders Market Size Market Share by Type (2017-2028)
    Figure 17. North America Gene Therapy for CNS Disorders Market Size Market Share by Application (2017-2028)
    Figure 18. North America Gene Therapy for CNS Disorders Market Size Share by Country (2017-2028)
    Figure 19. United States Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gene Therapy for CNS Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Gene Therapy for CNS Disorders Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Gene Therapy for CNS Disorders Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Gene Therapy for CNS Disorders Market Size Share by Country (2017-2028)
    Figure 25. Germany Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Gene Therapy for CNS Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Gene Therapy for CNS Disorders Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Gene Therapy for CNS Disorders Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Gene Therapy for CNS Disorders Market Size Share by Region (2017-2028)
    Figure 35. China Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Gene Therapy for CNS Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Gene Therapy for CNS Disorders Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Gene Therapy for CNS Disorders Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Gene Therapy for CNS Disorders Market Size Share by Country (2017-2028)
    Figure 45. Mexico Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Gene Therapy for CNS Disorders Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Gene Therapy for CNS Disorders Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Gene Therapy for CNS Disorders Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Gene Therapy for CNS Disorders Market Size Share by Country (2017-2028)
    Figure 51. Turkey Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Gene Therapy for CNS Disorders Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Gilead (Kite Pharma) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 55. Amgen (BioVex) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 57. Roche (Spark Therapeutics) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 58. Bluebird Bio Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed